CEREMARK PHARMA
Live / Applied — Second extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 01 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98386444
- Mark type
- Design + words
- Filed
- 01 Feb 2024
- Published for opposition
- 08 Oct 2024
- Attorney of record
- Bethany Salpietra
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for identifying radiological and biological markers of diseases; injectable solutions for medical purposes, namely, injectable pharmaceuticals for identifying radiological and biological markers of diseases and treating neurogenerative diseases; syringes sold with pharmaceuticals for identifying markers of diseases and treating neurodegenerative diseases
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; research and development in the field of medical and pharmaceutical preparations; research and development of vaccines and medicines
Owner
- CereMark Pharma, LLC, Wheeling, WV, US
- CereMark Pharma, LLC, Wheeling, WV, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 2 GRANTED
- 18 Nov 2025 — SOU EXTENSION 2 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 14 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2025 — SOU EXTENSION 1 GRANTED
- 13 May 2025 — SOU EXTENSION 1 FILED
- 13 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2024 — PUBLISHED FOR OPPOSITION
- 18 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
- 02 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED